Our Team

Our diverse and knowledgeable team leverages their combined business experience, deep scientific intelligence, and track record in drug development to make rationalized investment decisions.

Our all-inclusive approach ensures that we make measured investments with confidence for the benefit of our shareholders and patients.

  • KEN PASTOR

    MANAGING PARTNER

    • Founding Partner of the CTI Life Sciences Fund franchise.

    • 25+ years of investment banking, portfolio manager for major Canadian financial institution and a boutique investment firm.

    • Extensive expertise in negotiation, valuation of private and public companies, deal structuring and risk management.

  • LAURENCE RULLEAU

    MANAGING PARTNER

    • Partner at CTI LSF since 2014 and Life sciences Investor for over 25 years.

    • Deep experience in mergers and acquisitions as well as in/out-asset-licensing.

    • Active member of the life science ecosystem as a board director of Admare Bioinnovation and member of Women Innovating Together in Healthcare (WITH), Women in Bio (WIB) and Reseau-Elle.

  • YOUSSEF BENNANI

    MANAGING PARTNER

    • Pharmaceutical Executive, 30 years R&D experience.

    • Leadership, Management and Governance corporate experience.

    • Multi-therapeutic, disease-area expertise.

  • SHERMAINE TILLEY

    MANAGING PARTNER

    • Over 20 years of biotech investing and board experience, including as Partner in each of CTI LSF I – III.

    • Integrated scientific and financial structuring expertise associated with demonstrated returns.

    • Passionate about helping to shape innovative young businesses to achieve timely value inflection.

  • JEAN-FRANCOIS LEPRINCE

    MANAGING PARTNER

    • Seasoned executive with extensive multi-functional, multi-geographical experience in the pharmaceutical industry.

    • Co-founder of CTI Life Sciences Fund, key role in the establishment and enhancement of Fund’s franchise.

  • ANJAN ARALIHALLI

    VENTURE PARTNER

    • Pharmaceutical/Business Development Executive with 25+ years of international experience in multiple therapeutic areas.

    • Extensive US, EU & Japanese investor and pharma partner network.

    • Experience with start-up creation, corporate development, venture and angel financing, in & out-licensing as well as non-profits.

  • XIN HANG

    PRINCIPAL

    • Eight years of management consulting experience in supporting the acquisition and licensing deals.

    • Established opportunity assessment, forecasting, and valuation expert in the life science industry.

    • Driven to helping companies realize the commercial value of their next big scientific breakthrough.

  • PAUL CASSAR

    ASSOCIATE

    • Life Sciences investor, 10 years experience.

    • Business Development, Intellectual Property, Company Creation and Licensing experience.

    • Multi-therapeutic, disease-area expertise.

  • NICOLE NORTHCOTT

    EXECUTIVE ASSISTANT

    • More than 15 years of international experience.

    • Executive Assistant and Office Management roles.

    • Tri-lingual (English, French and Italian).